View in EDS HTML Full Text PDF Full Text

Safety, Tolerability and Pharmacokinetics of Intravenous Sodium Taurodeoxycholate, HY209, a GPCR19 Agonist Inhibiting Inflammasomal Activation.

Saved in:
Bibliographic Details
Title: Safety, Tolerability and Pharmacokinetics of Intravenous Sodium Taurodeoxycholate, HY209, a GPCR19 Agonist Inhibiting Inflammasomal Activation.
Authors: Chung WK; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea., Jeon I; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea., Jang IJ; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea., Seong SY; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea., Han SA; Shaperon Inc, Seoul, Republic of Korea., Yu KS; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
Source: Drug design, development and therapy [Drug Des Devel Ther] 2024 Dec 08; Vol. 18, pp. 5853-5861. Date of Electronic Publication: 2024 Dec 08 (Print Publication: 2024).
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN: 1177-8881 (Electronic) Linking ISSN: 11778881 NLM ISO Abbreviation: Drug Des Devel Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39670278
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety, Tolerability and Pharmacokinetics of Intravenous Sodium Taurodeoxycholate, HY209, a GPCR19 Agonist Inhibiting Inflammasomal Activation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chung+WK%22">Chung WK</searchLink>; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jeon+I%22">Jeon I</searchLink>; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jang+IJ%22">Jang IJ</searchLink>; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Seong+SY%22">Seong SY</searchLink>; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Han+SA%22">Han SA</searchLink>; Shaperon Inc, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Yu+KS%22">Yu KS</searchLink>; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101475745%22">Drug design, development and therapy</searchLink> [Drug Des Devel Ther] 2024 Dec 08; Vol. 18, pp. 5853-5861. <i>Date of Electronic Publication: </i>2024 Dec 08 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Dove+Press+Limited%22">Dove Press Limited </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101475745 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1177-8881 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211778881%22">11778881 </searchLink><i>NLM ISO Abbreviation: </i>Drug Des Devel Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39670278
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2147/DDDT.S438507
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 5853
    Titles:
      – TitleFull: Safety, Tolerability and Pharmacokinetics of Intravenous Sodium Taurodeoxycholate, HY209, a GPCR19 Agonist Inhibiting Inflammasomal Activation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chung WK
      – PersonEntity:
          Name:
            NameFull: Jeon I
      – PersonEntity:
          Name:
            NameFull: Jang IJ
      – PersonEntity:
          Name:
            NameFull: Seong SY
      – PersonEntity:
          Name:
            NameFull: Han SA
      – PersonEntity:
          Name:
            NameFull: Yu KS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 12
              Text: 2024 Dec 08
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1177-8881
          Numbering:
            – Type: volume
              Value: 18
          Titles:
            – TitleFull: Drug design, development and therapy
              Type: main
ResultId 1